Literature DB >> 25936583

Infections and risk-adjusted length of stay and hospital mortality in Polish Neonatology Intensive Care Units.

A Różańska1, J Wójkowska-Mach2, P Adamski3, M Borszewska-Kornacka4, E Gulczyńska5, M Nowiczewski5, E Helwich6, A Kordek7, D Pawlik8, M Bulanda2.   

Abstract

BACKGROUND: The objectives of this study were to analyze the impact of infections on prolonging hospital stay with consideration of underlying risk factors and determining the mortality rates and its association with infections.
METHODS: An electronic database developed from a continuous prospective targeted infection surveillance program was used in the study. Data were collected from 2009 to 2012 in five Polish tertiary academic neonatal intensive care units (NICUs). The length of stay (LOS) of 2,003 very low birth weight (VLBW) neonates was calculated as the sum of the number of days since birth until death or until reaching a weight of 1,800g.
RESULTS: The median LOS for neonates with infections was twice as high as for neonates without infection. LOS was significantly affected by the overall general condition of the neonate, as expressed by both gestational age and birth weight as well as by the Clinical Risk Index for Babies (CRIB) score; another independent factor was presence of at least one infection. Risk of in-hospital mortality was significantly increased by male sex and vaginal birth and was lower among breastfed neonates. Deaths were significantly more frequent in neonates without infection.
CONCLUSIONS: The general condition of VLBW infants statistically increase both their risk of mortality and LOS; this is in contrast to the presence of infection, which significantly prolonged LOS only.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  in-hospital mortality; length of stay; neonatal infections; very low birth weight

Mesh:

Year:  2015        PMID: 25936583     DOI: 10.1016/j.ijid.2015.04.017

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

1.  Impact of healthcare-associated sepsis on mortality in critically ill infants.

Authors:  Evelien Hilde Verstraete; Ludo Mahieu; Kris De Coen; Dirk Vogelaers; Stijn Blot
Journal:  Eur J Pediatr       Date:  2016-04-27       Impact factor: 3.183

2.  Antibiotic consumption in laboratory confirmed vs. non-confirmed bloodstream infections among very low birth weight neonates in Poland.

Authors:  A Różańska; J Wójkowska-Mach; P Adamski; M Borszewska-Kornacka; E Gulczyńska; M Nowiczewski; E Helwich; A Kordek; D Pawlik; M Bulanda
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-03-31       Impact factor: 3.944

3.  Predicting emergency departments visit rates from septicemia in Taiwan using an age-period-cohort model, 1998 to 2012.

Authors:  I-Shiang Tzeng; Su-Hsun Liu; Yu Ting Chiou; Chien-Hsiung Huang; Cheng-Jung Lee; Cheng-Yu Chien; Shou-Chien Hsu; Yi-Ming Weng; Kuan-Fu Chen; Jih-Chang Chen
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

4.  Elevated Levels of Interleukin-27 in Early Life Compromise Protective Immunity in a Mouse Model of Gram-Negative Neonatal Sepsis.

Authors:  Jordan K Vance; Travis W Rawson; Brittany G Seman; Michelle R Witt; Annalisa B Huckaby; Jessica M Povroznik; Shelby D Bradford; Mariette Barbier; Cory M Robinson
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

Review 5.  Neonate Bloodstream Infections in Organization for Economic Cooperation and Development Countries: An Update on Epidemiology and Prevention.

Authors:  Jadwiga Wójkowska-Mach; Agnieszka Chmielarczyk; Magdalena Strus; Ryszard Lauterbach; Piotr Heczko
Journal:  J Clin Med       Date:  2019-10-21       Impact factor: 4.241

6.  Colonization with hospital flora and its associated risk factors in neonates hospitalized in neonatal ward of a teaching center in Isfahan, Iran.

Authors:  Kiana Shirani; Kamyar Mostafavizadeh; Behrouz Ataei; Khatere Akhani
Journal:  J Res Med Sci       Date:  2018-01-29       Impact factor: 1.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.